Effects of cilazapril on endothelial function and pulmonary hypertension in patients with congestive heart failure

Simple item page
dc.contributor.authorTavli, T
dc.contributor.authorGocer, H
dc.date.accessioned2024-07-18T11:49:16Z
dc.date.available2024-07-18T11:49:16Z
dc.description.abstractFlow-mediated vasodilation (FMV), brachial artery flow (BAF), and brachial artery diameter were evaluated in 30 patients with congestive heart failure before and after cilazapril treatment. While mean pulmonary artery pressure and Pulmonary capillary wedge pressure decreased significantly, flow-mediated vasodilation and left ventricular ejection fraction increased significantly following cilazapril administration (P<0.001). Brachial artery diameter and brachial artery flow did not change following the treatment period (P>0.05). In conclusion, short term cilazapril administration improved endothelial function and pulmonary pressure in patients with congestive heart failure.
dc.identifier.issn0021-4868
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/3880
dc.language.isoEnglish
dc.publisherINT HEART JOURNAL ASSOC
dc.subjectANGIOTENSIN-CONVERTING ENZYME
dc.subjectNITRIC-OXIDE
dc.subjectINHIBITION
dc.subjectCORONARY
dc.subjectARTERIES
dc.subjectVASODILATION
dc.subjectDYSFUNCTION
dc.titleEffects of cilazapril on endothelial function and pulmonary hypertension in patients with congestive heart failure
dc.typeArticle; Proceedings Paper

Files

Collections

Web of Science Koleksiyonu